Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elham Kayvanpour

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Current Heart Failure Reports|August 3, 2015
Determined to Fail--the Role of Genetic Mechanisms in Heart FailureElham Kayvanpour, Hugo A Katus, Benjamin Meder
Reviews in Cardiovascular Medicine|February 9, 2026
Targeting the Sarcomere: Myosin Inhibitors as the Revolutionary Game Changer in Hypertrophic CardiomyopathyFarbod Sedaghat-Hamedani, Elham Kayvanpour, Benjamin Meder
Stem Cell Research|July 17, 2020
Generation of pluripotent stem cell lines and CRISPR/Cas9 modified isogenic controls from a patient with dilated cardiomyopathy harboring a RBM20 p.R634W mutationSabine Rebs, Farbod Sedaghat-Hamedani, Elham Kayvanpour, et al.
Acta Medica Iranica|November 11, 2011
A bulking agent may lead to adrenal insufficiency crisis: a case reportSalma Ahi, Majid Esmaeilzadeh, Elham Kayvanpour, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 30, 2014
Post cardiac injury syndrome after initially uncomplicated CRT-D implantation: a case report and a systematic reviewFarbod Sedaghat-Hamedani, Edgar Zitron, Elham Kayvanpour, et al.
Journal of Cardiovascular Development and Disease|June 26, 2024
Comparative Assessment of Percutaneous Left-Atrial Appendage Occlusion (LAAO) Devices-A Single Center Cohort StudyElham Kayvanpour, Max Kothe, Ziya Kaya, et al.
Stem Cell Research|December 23, 2023
Generation of an RBM20-mutation-associated left-ventricular non-compaction cardiomyopathy iPSC line (UMGi255-A) into a DCM genetic background to investigate monogenetic cardiomyopathiesHanna Eberl, Sabine Rebs, Stefanie Hoppe, et al.
Journal of Clinical Medicine|March 27, 2025
Efficacy and Safety of Percutaneous ASD Closure in Adults: Comparative Outcomes of Occluder Devices in a Single-Center CohortElham Kayvanpour, Elena Matzeit, Christoph Reich, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
Assessing the Applicability of Cardiac Myosin Inhibitors for Hypertrophic Cardiomyopathy Management in a Large Single Center CohortAli Amr, Elham Kayvanpour, Christoph Reich, et al.
Biomolecules|September 28, 2024
Prognostic Value of Circulating Fibrosis Biomarkers in Dilated Cardiomyopathy (DCM): Insights into Clinical OutcomesElham Kayvanpour, Farbod Sedaghat-Hamedani, Daniel Tian Li, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Current Heart Failure Reports|August 3, 2015
Determined to Fail--the Role of Genetic Mechanisms in Heart FailureElham Kayvanpour, Hugo A Katus, Benjamin Meder
Reviews in Cardiovascular Medicine|February 9, 2026
Targeting the Sarcomere: Myosin Inhibitors as the Revolutionary Game Changer in Hypertrophic CardiomyopathyFarbod Sedaghat-Hamedani, Elham Kayvanpour, Benjamin Meder
Stem Cell Research|July 17, 2020
Generation of pluripotent stem cell lines and CRISPR/Cas9 modified isogenic controls from a patient with dilated cardiomyopathy harboring a RBM20 p.R634W mutationSabine Rebs, Farbod Sedaghat-Hamedani, Elham Kayvanpour, et al.
Acta Medica Iranica|November 11, 2011
A bulking agent may lead to adrenal insufficiency crisis: a case reportSalma Ahi, Majid Esmaeilzadeh, Elham Kayvanpour, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 30, 2014
Post cardiac injury syndrome after initially uncomplicated CRT-D implantation: a case report and a systematic reviewFarbod Sedaghat-Hamedani, Edgar Zitron, Elham Kayvanpour, et al.
Journal of Cardiovascular Development and Disease|June 26, 2024
Comparative Assessment of Percutaneous Left-Atrial Appendage Occlusion (LAAO) Devices-A Single Center Cohort StudyElham Kayvanpour, Max Kothe, Ziya Kaya, et al.
Stem Cell Research|December 23, 2023
Generation of an RBM20-mutation-associated left-ventricular non-compaction cardiomyopathy iPSC line (UMGi255-A) into a DCM genetic background to investigate monogenetic cardiomyopathiesHanna Eberl, Sabine Rebs, Stefanie Hoppe, et al.
Journal of Clinical Medicine|March 27, 2025
Efficacy and Safety of Percutaneous ASD Closure in Adults: Comparative Outcomes of Occluder Devices in a Single-Center CohortElham Kayvanpour, Elena Matzeit, Christoph Reich, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
Assessing the Applicability of Cardiac Myosin Inhibitors for Hypertrophic Cardiomyopathy Management in a Large Single Center CohortAli Amr, Elham Kayvanpour, Christoph Reich, et al.
Biomolecules|September 28, 2024
Prognostic Value of Circulating Fibrosis Biomarkers in Dilated Cardiomyopathy (DCM): Insights into Clinical OutcomesElham Kayvanpour, Farbod Sedaghat-Hamedani, Daniel Tian Li, et al.
Pageof 7